The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Milk Oligosaccharides (HMO) Market Research Report 2025
Synopsis
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
The global Human Milk Oligosaccharides (HMO) market was valued at US$ 467.7 million in 2023 and is anticipated to reach US$ 1227.5 million by 2030, witnessing a CAGR of 14.5% during the forecast period 2024-2030.
Global key players of human milk oligosaccharides (HMO) include Abbott, Glycom, Chr. Hansen (Jennewein), etc. The top three players hold a share about 81%. North America is the largest market, has a share about 47%, followed by Europe and Asia-Pacific, with share 33% and 19%, separately.
This report aims to provide a comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Milk Oligosaccharides (HMO).
Report Scope
The Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
Segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.
Segment by Application
Infant Formula
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
The global Human Milk Oligosaccharides (HMO) market was valued at US$ 467.7 million in 2023 and is anticipated to reach US$ 1227.5 million by 2030, witnessing a CAGR of 14.5% during the forecast period 2024-2030.
Global key players of human milk oligosaccharides (HMO) include Abbott, Glycom, Chr. Hansen (Jennewein), etc. The top three players hold a share about 81%. North America is the largest market, has a share about 47%, followed by Europe and Asia-Pacific, with share 33% and 19%, separately.
This report aims to provide a comprehensive presentation of the global market for Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Milk Oligosaccharides (HMO).
Report Scope
The Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
Segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.
Segment by Application
Infant Formula
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Milk Oligosaccharides (HMO) Market Overview
1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)
1.2 Human Milk Oligosaccharides (HMO) Segment by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Market Value Comparison by Type (2024-2030)
1.2.2 2'-FL & 3-FL
1.2.3 LNT & LNnT, etc.
1.3 Human Milk Oligosaccharides (HMO) Segment by Application
1.3.1 Global Human Milk Oligosaccharides (HMO) Market Value by Application: (2024-2030)
1.3.2 Infant Formula
1.3.3 Others
1.4 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts
1.4.1 Global Human Milk Oligosaccharides (HMO) Revenue 2019-2030
1.4.2 Global Human Milk Oligosaccharides (HMO) Sales 2019-2030
1.4.3 Global Human Milk Oligosaccharides (HMO) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Milk Oligosaccharides (HMO) Market Competition by Manufacturers
2.1 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2019-2024)
2.4 Global Human Milk Oligosaccharides (HMO) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Milk Oligosaccharides (HMO), Product Type & Application
2.7 Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends
2.7.1 Human Milk Oligosaccharides (HMO) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Milk Oligosaccharides (HMO) Players Market Share by Revenue
2.7.3 Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Milk Oligosaccharides (HMO) Retrospective Market Scenario by Region
3.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Milk Oligosaccharides (HMO) Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2030
3.2.1 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2019-2024
3.2.2 Global Human Milk Oligosaccharides (HMO) Sales by Region: 2025-2030
3.3 Global Human Milk Oligosaccharides (HMO) Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2030
3.3.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2019-2024
3.3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2025-2030
3.4 North America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.4.1 North America Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.4.3 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.5.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.5.3 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.6.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.7.1 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.7.3 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2030)
4.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Type (2019-2024)
4.1.2 Global Human Milk Oligosaccharides (HMO) Sales by Type (2025-2030)
4.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2019-2030)
4.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2030)
4.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2019-2024)
4.2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type (2025-2030)
4.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2030)
4.3 Global Human Milk Oligosaccharides (HMO) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2030)
5.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Application (2019-2024)
5.1.2 Global Human Milk Oligosaccharides (HMO) Sales by Application (2025-2030)
5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2019-2030)
5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2030)
5.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2019-2024)
5.2.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application (2025-2030)
5.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2030)
5.3 Global Human Milk Oligosaccharides (HMO) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Inbiose
6.2.1 Inbiose Corporation Information
6.2.2 Inbiose Description and Business Overview
6.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
6.2.5 Inbiose Recent Developments/Updates
6.3 Glycom
6.3.1 Glycom Corporation Information
6.3.2 Glycom Description and Business Overview
6.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
6.3.5 Glycom Recent Developments/Updates
6.4 Chr. Hansen (Jennewein)
6.4.1 Chr. Hansen (Jennewein) Corporation Information
6.4.2 Chr. Hansen (Jennewein) Description and Business Overview
6.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Portfolio
6.4.5 Chr. Hansen (Jennewein) Recent Developments/Updates
6.5 Elicityl SA
6.5.1 Elicityl SA Corporation Information
6.5.2 Elicityl SA Description and Business Overview
6.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
6.5.5 Elicityl SA Recent Developments/Updates
6.6 ZuChem
6.6.1 ZuChem Corporation Information
6.6.2 ZuChem Description and Business Overview
6.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
6.6.5 ZuChem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Milk Oligosaccharides (HMO) Industry Chain Analysis
7.2 Human Milk Oligosaccharides (HMO) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Milk Oligosaccharides (HMO) Production Mode & Process
7.4 Human Milk Oligosaccharides (HMO) Sales and Marketing
7.4.1 Human Milk Oligosaccharides (HMO) Sales Channels
7.4.2 Human Milk Oligosaccharides (HMO) Distributors
7.5 Human Milk Oligosaccharides (HMO) Customers
8 Human Milk Oligosaccharides (HMO) Market Dynamics
8.1 Human Milk Oligosaccharides (HMO) Industry Trends
8.2 Human Milk Oligosaccharides (HMO) Market Drivers
8.3 Human Milk Oligosaccharides (HMO) Market Challenges
8.4 Human Milk Oligosaccharides (HMO) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
